애널리스트 10명 기준
목표가는 개별 리서치펌 단위가 아닌 시장 컨센서스(평균/최고/최저)입니다. 수집 액션 40건 · 최근 12개월 22건.
| 날짜 | 리서치펌 | 애널리스트 | 액션 | 의견 변화 | 목표가 | 리포트 |
|---|---|---|---|---|---|---|
| 2026. 05. 19. | Chardan Capital | — | 의견 유지 | Buy → Buy | — | Chardan Capital: Buy |
| 2026. 05. 15. | Wells Fargo | — | 의견 유지 | Overweight → Overweight | — | Wells Fargo: Overweight |
| 2026. 05. 15. | Guggenheim | — | 의견 유지 | Buy → Buy | — | Guggenheim: Buy |
| 2026. 05. 15. | HC Wainwright & Co. | — | 투자의견 하향 | Buy → Neutral | — | HC Wainwright & Co.: Buy → Neutral |
| 2026. 03. 30. | Oppenheimer | — | 의견 유지 | Outperform → Outperform | — | Oppenheimer: Outperform |
| 2026. 03. 30. | Chardan Capital | — | 의견 유지 | Buy → Buy | — | Chardan Capital: Buy |
| 2026. 03. 30. | HC Wainwright & Co. | — | 의견 유지 | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2026. 03. 20. | Morgan Stanley | — | 의견 유지 | Overweight → Overweight | — | Morgan Stanley: Overweight |
| 2026. 03. 20. | Chardan Capital | — | 의견 유지 | Buy → Buy | — | Chardan Capital: Buy |
| 2026. 03. 11. | Raymond James | — | 커버리지 개시 | — → Strong Buy | — | Raymond James: Strong Buy |
| 2026. 02. 25. | Stifel | — | 커버리지 개시 | — → Buy | — | Stifel: Buy |
| 2026. 01. 21. | Chardan Capital | — | 커버리지 개시 | — → Buy | — | Chardan Capital: Buy |
| 2026. 01. 09. | HC Wainwright & Co. | — | 의견 유지 | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2026. 01. 08. | Leerink Partners | — | 의견 유지 | Outperform → Outperform | — | Leerink Partners: Outperform |
| 2026. 01. 08. | Morgan Stanley | — | 의견 유지 | Overweight → Overweight | — | Morgan Stanley: Overweight |
| 2026. 01. 07. | Guggenheim | — | 의견 유지 | Buy → Buy | — | Guggenheim: Buy |
| 2026. 01. 07. | Wells Fargo | — | 의견 유지 | Overweight → Overweight | — | Wells Fargo: Overweight |
| 2025. 12. 19. | HC Wainwright & Co. | — | 의견 유지 | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 08. 15. | Morgan Stanley | — | 의견 유지 | Overweight → Overweight | — | Morgan Stanley: Overweight |
| 2025. 08. 14. | HC Wainwright & Co. | — | 의견 유지 | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 07. 25. | Wells Fargo | — | 커버리지 개시 | — → Overweight | — | Wells Fargo: Overweight |
| 2025. 07. 25. | HC Wainwright & Co. | — | 의견 유지 | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 05. 16. | Oppenheimer | — | 의견 유지 | Outperform → Outperform | — | Oppenheimer: Outperform |
| 2025. 04. 30. | HC Wainwright & Co. | — | 의견 유지 | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 04. 22. | HC Wainwright & Co. | — | 의견 유지 | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 03. 26. | HC Wainwright & Co. | — | 의견 유지 | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 03. 20. | Cantor Fitzgerald | — | 의견 유지 | Overweight → Overweight | — | Cantor Fitzgerald: Overweight |
| 2025. 03. 20. | HC Wainwright & Co. | — | 의견 유지 | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 03. 11. | HC Wainwright & Co. | — | 의견 유지 | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 03. 10. | HC Wainwright & Co. | — | 의견 유지 | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 03. 03. | HC Wainwright & Co. | — | 의견 유지 | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 02. 07. | HC Wainwright & Co. | — | 의견 유지 | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 01. 31. | Oppenheimer | — | 커버리지 개시 | — → Outperform | — | Oppenheimer: Outperform |
| 2025. 01. 06. | HC Wainwright & Co. | — | 의견 유지 | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2024. 12. 20. | HC Wainwright & Co. | — | 의견 유지 | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2024. 11. 14. | Cantor Fitzgerald | — | 의견 유지 | — → Overweight | — | Cantor Fitzgerald: Overweight |
| 2024. 11. 14. | HC Wainwright & Co. | — | 의견 유지 | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2024. 10. 31. | Baird | — | 커버리지 개시 | — → Outperform | — | Baird: Outperform |
| 2024. 10. 17. | HC Wainwright & Co. | — | 커버리지 개시 | — → Buy | — | HC Wainwright & Co.: Buy |
| 2024. 08. 20. | Cantor Fitzgerald | — | 의견 유지 | — → Overweight | — | Cantor Fitzgerald: Overweight |